Structures Speak up
As structure determination becomes a high-throughput tool for optimizing drug leads, biotech companies apply it to contract research as well as their own portfolios
Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Copyright © 2024 American Chemical Society
September 20, 2004 Cover
Volume 82, Issue 38
As structure determination becomes a high-throughput tool for optimizing drug leads, biotech companies apply it to contract research as well as their own portfolios
Credit:
Pharmaceuticals
Silicon Completes Triple Crown
First stable compound with a silicon-silicon triple bond is synthesized
Joseph Priestley Remembered
Discoverer of oxygen and other gases played key role in history of chemistry
-
Rising Stars of Industrial Research
Symposium recognizes the talent and innovative contributions of young R&D scientists
-
Eastman Chemical: Ready to Grow
The firm has been trimming down for two years and thinks it's fit enough to pursue growth again
-
'Marching In' on NIH-funded Drugs
Consumer group asks agency to use rights under Bayh-Dole Act to ensure reasonable drug prices
ADVERTISEMENT
Science Concentrates
Tough Road to Agrochemicals
Symposia chart the hurdles involved in turning a pesticide lead into a commercial product
